Patents by Inventor Luther E. Lindler

Luther E. Lindler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plasmid DNA from Yersinia pestis
    Patent number: 6706522
    Abstract: The complete DNA sequence of three plasmids from the bacterium Yersinia pestis, the causative agent for bubonic plague, have been determined and are set forth. The open reading frames, or protein coding regions, of the plasmids have been determined. The DNA sequence and ORF information is useful for the creation of diagnostic, prophylactic and therapeutic tools for combating the disease caused by this agent.
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: March 16, 2004
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Frederick R. Blattner, Valerie Burland, Debra J. Rose, George F. Mayhew, Nicole Perna, Robert D Perry, Susan C Straley, Jacqueline D. Fetherston, Luther E. Lindler, Gregory V. Plano
  • Protein from brucella species
    Publication number: 20030082170
    Abstract: A 28 kDa protein which has use as a diagnostic agent for identifying antibodies to Brucella species and as vaccines to raise antibodies against several species of Brucella has been purified.
    Type: Application
    Filed: February 20, 2001
    Publication date: May 1, 2003
    Inventors: Luther E. Lindler, Richard Warren, Lillian VanDeVerg, Fran Rubin
  • Live vaccine against Brucellosis
    Patent number: 6444445
    Abstract: Live Brucella vaccines and methods for preparing the live vaccines protective against brucellosis are described. The vaccines are prepared by introducing a deletion in the rfbU gene of a strain of Brucella which results in attenuation of the strain while retaining the desired immunogenicity to initiate a protective immunogenic response. Other strains with varying levels of attenuation are described.
    Type: Grant
    Filed: January 22, 1998
    Date of Patent: September 3, 2002
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Mikeljon P. Nikolich, David L. Hoover, Richard L. Warren, Luther E. Lindler, Ted L. Hadfield, Gerhardt G. Schurig, Stephen M. Boyle, John R. McOulston, Nammalwar Sriranganathan
  • LIVE VACCINE AGAINST BRUCELLOSIS
    Publication number: 20010014673
    Abstract: Live Brucella vaccines and methods for preparing the live vaccines protective against brucellosis are described. The vaccines are prepared by introducing a deletion in the rfbU gene of a strain of Brucella which results in attenuation of the strain while retaining the desired immunogenicity to initiate a protective immunogenic response. Other strains with varying levels of attenuation are described.
    Type: Application
    Filed: January 22, 1998
    Publication date: August 16, 2001
    Inventors: MIKELJON P. NIKOLICH, DAVID L. HOOVER, RICHARD L. WARREN, LUTHER E. LINDLER, TED L. HADFIELD, CERHARDT G. SCHURIG, STEPHEN M. BOYLE, JOHN R. MCOULSTON, NAMMALWAR SRIRANGANATHAN